Thymic Stromal Lymphopoietin is Induced by Respiratory Syncytial Virus-infected Airway Epithelial Cells and Promotes a Type 2 Response to Infection
Overview
Authors
Affiliations
Background: Respiratory viral infection, including respiratory syncytial virus (RSV) and rhinovirus, has been linked to respiratory disease in pediatric patients, including severe acute bronchiolitis and asthma exacerbation.
Objective: The study examined the role of the epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) in the response to RSV infection.
Methods: Infection of human airway epithelial cells was used to examine TSLP induction after RSV infection. Air-liquid interface cultures from healthy children and children with asthma were also tested for TSLP production after infection. Finally, a mouse model was used to directly test the role of TSLP signaling in the response to RSV infection.
Results: Infection of airway epithelial cells with RSV led to the production of TSLP via activation of an innate signaling pathway that involved retinoic acid induced gene I, interferon promoter-stimulating factor 1, and nuclear factor-κB. Consistent with this observation, airway epithelial cells from asthmatic children a produced significantly greater levels of TSLP after RSV infection than cells from healthy children. In mouse models, RSV-induced TSLP expression was found to be critical for the development of immunopathology.
Conclusion: These findings suggest that RSV can use an innate antiviral signaling pathway to drive a potentially nonproductive immune response and has important implications for the role of TSLP in viral immune responses in general.
T1-T2 Interplay in the Complex Immune Landscape of Severe Asthma.
Gauthier M, Kale S, Ray A Immunol Rev. 2025; 330(1):e70011.
PMID: 39991821 PMC: 11849004. DOI: 10.1111/imr.70011.
Zaied R, Gokuladhas S, Walker C, OSullivan J Front Immunol. 2024; 15:1412032.
PMID: 39628479 PMC: 11611866. DOI: 10.3389/fimmu.2024.1412032.
Mubarak A, Alqoufail M, Almutairi S, Alrfaei B, Almotairi A, Aziz I Infect Drug Resist. 2024; 17:4589-4598.
PMID: 39469096 PMC: 11513571. DOI: 10.2147/IDR.S483133.
Djeddi S, Fernandez-Salinas D, Huang G, Aguiar V, Mohanty C, Kendziorski C Cell Genom. 2024; 4(9):100636.
PMID: 39197446 PMC: 11480861. DOI: 10.1016/j.xgen.2024.100636.
Early-life risk factors which govern pro-allergic immunity.
Ptaschinski C, Gibbs B Semin Immunopathol. 2024; 46(3-4):9.
PMID: 39066790 PMC: 11283399. DOI: 10.1007/s00281-024-01020-x.